MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
11.58
-0.35
-2.89%
Opening 13:05 12/16 EST
OPEN
11.76
PREV CLOSE
11.92
HIGH
11.85
LOW
11.55
VOLUME
394.94K
TURNOVER
--
52 WEEK HIGH
19.12
52 WEEK LOW
4.720
MARKET CAP
1.50B
P/E (TTM)
-13.0393
1D
5D
1M
3M
1Y
5Y
1D
NeoGenomics price target raised to $13 from $11 at BofA
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Champions Oncology (CSBR) and NeoGenomics (NEO)
TipRanks · 1d ago
NeoGenomics announce Natera withdrawal of appeal in patent litigation
TipRanks · 1d ago
Natera Ends Lawsuit, Clearing Path for NeoGenomics' RaDaR ST Launch
Benzinga · 1d ago
Natera Drops Appeal in Patent Dispute With NeoGenomics
Reuters · 1d ago
NEOGENOMICS ANNOUNCES THAT NATERA HAS VOLUNTARILY WITHDRAWN ITS APPEAL IN ONGOING RADAR PATENT LITIGATION
Reuters · 1d ago
NEOGENOMICS INC - DISMISSAL LEAVES RULING IN NEOGENOMICS' FAVOR
Reuters · 1d ago
Weekly Report: what happened at NEO last week (1208-1212)?
Weekly Report · 1d ago
More
About NEO
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.